Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001079973-25-000408·S.H.N. Financial Investments Ltd.
Schedule 13G ownership disclosure
Tenax Therapeutics, Inc.
Common stock, par value $0.0001 · CUSIP: 88032L605
Event date: 2024-12-31
- Filing-level shares
- 179,050.00
- Percent of class
- 4.99%
- S.H.N. Financial Investments Ltd.
Shares: 179,050.00 · Class: 4.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001079973-25-000408
- Form type
- SCHEDULE 13G/A
- Filer
- S.H.N. Financial Investments Ltd.
- CIK
- CIK 1890802
- Filed
- Mar 18, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership